Aminoglycoside-Ca++ interactions in skeletal muscle preparations.
D000251:Adenosine Triphosphatases; D000617:Aminoglycosides / Q000494:pharmacology*; D000818:Animals; D001665:Binding Sites / Q000187:drug effects; D002118:Calcium / Q000037:antagonists & inhibitors* / Q000378:metabolism; D003864:Depression, Chemical; D003900:Desoxycorticosterone / Q000494:pharmacology; D008274:Magnesium; D009132:Muscles / Q000187:drug effects* / Q000648:ultrastructure; D009355:Neomycin / Q000008:administration & dosage / Q000494:pharmacology; D009407:Nerve Block; D011817:Rabbits; D012519:Sarcoplasmic Reticulum / Q000187:drug effects / Q000378:metabolism; D013307:Streptomycin / Q000494:pharmacology
D000617:Aminoglycosides; D003900:Desoxycorticosterone; D000251:Adenosine Triphosphatases; D009355:Neomycin; D008274:Magnesium; D002118:Calcium; D013307:Streptomycin